drugset / Trial / NCT06188611
A Phase IV Study of Huazhi Rougan Granule
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Placebo control, Randomized, Double-blind, Multicenter Phase IV study to investigate the efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic simple fatty liver (damp-heat obstruction syndrome: Shi-Re-Zhong-Zu Zheng)
Timeline
- Start
- 2017-05-18
- Primary completion
- 2018-11-08
- Completion
- 2018-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huazhi Rougan Granule | Unknown | — | Oral |
Indications
No indication recorded.